1166 related articles for article (PubMed ID: 19497926)
21. [Type 2 diabetic: risk same as after infarct. With LDL not only the quantity counts].
MMW Fortschr Med; 2004 Jun; 146(24):4. PubMed ID: 15366509
[No Abstract] [Full Text] [Related]
22. Statins targeting inflammation by lowering low-density lipoprotein?
Tuzcu EM; Nicholls SJ
J Am Coll Cardiol; 2007 May; 49(20):2010-2. PubMed ID: 17512356
[No Abstract] [Full Text] [Related]
23. In brief: Zetia and Vytorin: the ENHANCE study.
Med Lett Drugs Ther; 2008 Jan; 50(1278):5. PubMed ID: 18219263
[No Abstract] [Full Text] [Related]
24. Clinical trials and tribulations. Cholesterol veers off script.
Couzin J
Science; 2008 Oct; 322(5899):220-3. PubMed ID: 18845747
[No Abstract] [Full Text] [Related]
25. [Aggressive therapy and combination therapy in severe hyperlipidemia].
Kostner KM
Wien Med Wochenschr; 1999; 149(5-6):146-8. PubMed ID: 10408007
[TBL] [Abstract][Full Text] [Related]
26. [Cholesterol goals are now easier to reach. Half LDL cholesterol with only one tablet daily].
MMW Fortschr Med; 2005 Nov; 147(45):55. PubMed ID: 16320656
[No Abstract] [Full Text] [Related]
27. When a statin fails.
Med Lett Drugs Ther; 2009 Jul; 51(1317):58-60. PubMed ID: 19636290
[No Abstract] [Full Text] [Related]
28. [Ezetimibe--intestinal cholesterol absorbtion inhibitor].
Pikto-Pietkiewicz W; Pasierski T
Kardiol Pol; 2006 Dec; 64(12):1434-41. PubMed ID: 17206545
[No Abstract] [Full Text] [Related]
29. Low-density lipoprotein lowering therapy: an analysis of the options.
Sacks FM
J Am Coll Cardiol; 2002 Dec; 40(12):2135-8. PubMed ID: 12505225
[No Abstract] [Full Text] [Related]
30. New developments in pharmacotherapy.
Thompson GR
Cardiovasc J S Afr; 2004; 15(2):56-8. PubMed ID: 15148538
[No Abstract] [Full Text] [Related]
31. [Statin and absorption inhibitor work synergistically. More risk patient reach LDL cholesterol goal value].
MMW Fortschr Med; 2007 Apr; 149(17):56-7. PubMed ID: 17674912
[No Abstract] [Full Text] [Related]
32. No effect of lipid lowering on platelet activity in patients with coronary artery disease and type 2 diabetes or impaired glucose tolerance.
Malmström RE; Settergren M; Böhm F; Pernow J; Hjemdahl P
Thromb Haemost; 2009 Jan; 101(1):157-64. PubMed ID: 19132203
[TBL] [Abstract][Full Text] [Related]
33. [New combination therapy. Up to 60% lower LDL cholesterol level].
MMW Fortschr Med; 2004 May; 146(19):63. PubMed ID: 15357489
[No Abstract] [Full Text] [Related]
34. Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study.
Farnier M; Averna M; Missault L; Vaverkova H; Viigimaa M; Massaad R; Vandormael K; Johnson-Levonas AO; Brudi P
Int J Clin Pract; 2009 Apr; 63(4):547-59. PubMed ID: 19222610
[TBL] [Abstract][Full Text] [Related]
35. Effect of ezetimibe coadministration with simvastatin in a Middle Eastern population: a prospective, multicentre, randomized, double-blind, placebo-controlled trial.
Zubaid M; Shakir DK; Bazargani N; Binbrek A; Gopal R; Al-Tamimi O; Bakir S
J Cardiovasc Med (Hagerstown); 2008 Jul; 9(7):688-93. PubMed ID: 18545068
[TBL] [Abstract][Full Text] [Related]
36. [New studies of high dosage statins and fibrates. How is lipid lowering therapy changing? (interview by Dr. med. Dirk Einecke)].
Klose G
MMW Fortschr Med; 2005 Dec; 147(49-50):20. PubMed ID: 16401005
[No Abstract] [Full Text] [Related]
37. [Dual cholesterol inhibition. More high risk patients achieve LDL cholesterol values below 100 mg/dl].
MMW Fortschr Med; 2008 Jun; 150(23):39. PubMed ID: 18575369
[No Abstract] [Full Text] [Related]
38. Updated guidelines support even lower cholesterol levels for at-risk patients.
Levenson D
Rep Med Guidel Outcomes Res; 2004 Aug; 15(15):1, 6-7. PubMed ID: 15320342
[No Abstract] [Full Text] [Related]
39. Zetia (ezetimibe).
Kloner RA
Congest Heart Fail; 2003; 9(2):109-10. PubMed ID: 12671344
[No Abstract] [Full Text] [Related]
40. Ezetimibe + simvastatin (Merck/Schering-Plough).
Flores NA
Curr Opin Investig Drugs; 2004 Sep; 5(9):984-92. PubMed ID: 15503655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]